{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T06:04:52Z","timestamp":1775369092456,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.mce.2008.07.015","type":"journal-article","created":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T14:12:43Z","timestamp":1217859163000},"page":"51-58","source":"Crossref","is-referenced-by-count":19,"title":["Steroid-converting enzymes in human ovarian carcinomas"],"prefix":"10.1016","volume":"301","author":[{"given":"Justin C.","family":"Chura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung S.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Simard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris C.","family":"Brooker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H.","family":"Blomquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Argenta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2008.07.015_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.mce.2005.10.021","article-title":"Novel, potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1","volume":"248","author":"Allan","year":"2006","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.mce.2008.07.015_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2008.07.015_bib3","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial","volume":"359","author":"Baum","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2008.07.015_bib4","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1210\/en.136.9.3807","article-title":"Gene expression of 17beta-hydroxysteroid dehydrogenase type 2 isozyme in primary cultures of human trophoblasts predicts different mechanisms regulating type 1 and type 2 enzymes","volume":"136","author":"Beaudoin","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2008.07.015_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1677\/joe.0.1540379","article-title":"Expression of the genes for 3 beta-hydroxysteroid dehydrogenase type 1 and cytochrome P450scc during syncytium formation by human placental cytotrophoblast cells in culture and the regulation by progesterone and estradiol","volume":"154","author":"Beaudoin","year":"1997","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.mce.2008.07.015_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0960-0760(95)00200-6","article-title":"Kinetic analysis of enzymic activities: prediction of multiple forms of 17beta-hydroxysteroid dehydrogenase","volume":"55","author":"Blomquist","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2008.07.015_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0960-0760(02)00117-6","article-title":"Androgenic and estrogenic 17\u03b2-hydroxysteroid dehydrogenase\/17-ketosteroid reductase in human ovarian epithelial tumors: evidence for the types 1, 2 and 5 isoforms","volume":"81","author":"Blomquist","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2008.07.015_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.steroids.2004.03.002","article-title":"Inhibition of type 2 17\u03b2-hydroxysteroid dehydrogenase by estradiol derivatives bearing a lactone on the D-ring: structure\u2013activity relationships","volume":"69","author":"Bydal","year":"2004","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2008.07.015_bib9","unstructured":"Bydal, P., Luu-The, V., Poirier, P., in press. Steroidal lactones as inhibitors of 17\u03b2-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities. Eur. J. Med. Chem."},{"key":"10.1016\/j.mce.2008.07.015_bib10","first-page":"6442","article-title":"Inhibition of estrone-sulfatase induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase","volume":"63","author":"Ciobanu","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2008.07.015_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1749-6632.2001.tb04012.x","article-title":"Quality of life and tamoxifen in a breast cancer prevention trial: a summary of findings from the NSABP P-1 study. National Surgical Adjuvant Breast and Bowel Project","volume":"949","author":"Day","year":"2001","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.mce.2008.07.015_bib12","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ygyno.2003.08.021","article-title":"Phase II trial of anastrozole in women with asymptomatic M\u00fcllerian cancer","volume":"91","author":"del Carmen","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mce.2008.07.015_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jsbmb.2004.12.035","article-title":"Inhibition of 17beta-hydroxysteroid dehydrogenases by phytoestrogens: comparison with other steroid metabolizing enzymes","volume":"93","author":"Deluca","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2008.07.015_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/1097-0142(19910715)68:2<269::AID-CNCR2820680209>3.0.CO;2-O","article-title":"Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patients","volume":"68","author":"Hatch","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.mce.2008.07.015_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0022-4731(81)90280-6","article-title":"Studies of estrogen metabolism in postmenopausal women with cancer","volume":"15","author":"James","year":"1981","journal-title":"J. Seroid Biochem."},{"key":"10.1016\/j.mce.2008.07.015_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics CA cancer","volume":"58","author":"Jemal","year":"2008","journal-title":"J. Clin."},{"key":"10.1016\/j.mce.2008.07.015_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/00016348609155172","article-title":"Gonadal steroids, gonadotropins, and endometrial histology in postmenopausal women with malignant ovarian tumors","volume":"65","author":"Jeppsson","year":"1986","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.mce.2008.07.015_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0002-9378(80)91043-1","article-title":"Serum androgens and estrogens in postmenopausal women with and without endometrial cancer","volume":"136","author":"Judd","year":"1980","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2008.07.015_bib19","first-page":"45","article-title":"Aromatase in human common epithelial ovarian neoplasms","volume":"149","author":"Kaga","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2008.07.015_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/09513590601058333","article-title":"Conversion of circulating estrone sulfate to 17\u03b2-estradiol by ovarian tumor tissue: a possible mechanism being elevated circulating concentrations of 17\u03b2-estradiol in postmenopausal women with ovarian tumors","volume":"23","author":"Kirilovas","year":"2007","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.mce.2008.07.015_bib21","doi-asserted-by":"crossref","first-page":"C113","DOI":"10.1016\/0303-7207(91)90116-A","article-title":"Intracrinology","volume":"78","author":"Labrie","year":"1991","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.mce.2008.07.015_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.1995.tb17369.x","article-title":"DHEA and peripheral androgen and estrogen formation: intracrinology","volume":"774","author":"Labrie","year":"1995","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.mce.2008.07.015_bib23","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.bmc.2007.11.007","article-title":"Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone","volume":"16","author":"Laplante","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.mce.2008.07.015_bib24","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1210\/me.11.13.1971","article-title":"Expression and characterization of recombinant type 2 3alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 alpha\/17beta-HSD activity and cellular distribution","volume":"11","author":"Lin","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2008.07.015_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2005.11.031","article-title":"Multifunctionality of human 17\u03b2-hydroxysteroid dehydrogenases","volume":"248","author":"Moeller","year":"2006","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.mce.2008.07.015_bib26","first-page":"836","article-title":"Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organisation","volume":"1","author":"NATO writing group","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2008.07.015_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/0264-6021:3510067","article-title":"Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the also-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones","volume":"351","author":"Penning","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.mce.2008.07.015_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/humupd\/dmg022","article-title":"Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action","volume":"9","author":"Penning","year":"2003","journal-title":"Human Reprod. Update"},{"key":"10.1016\/j.mce.2008.07.015_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0022-4731(80)90117-X","article-title":"The conversion of androstenedione to estrone, estradiol, and testosterone in breast tissue","volume":"13","author":"Perel","year":"1980","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.mce.2008.07.015_bib30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/0929867033368222","article-title":"Inhibitors of 17\u03b2-hydroxysteroid dehydrogenases","volume":"10","author":"Poirier","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.mce.2008.07.015_bib31","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1210\/en.141.8.2786","article-title":"Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3","volume":"141","author":"Provost","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2008.07.015_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1164\/rccm.200312-1680OC","article-title":"A link between lung androgen metabolism and the emergence of mature epithelial type II cells","volume":"170","author":"Provost","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.mce.2008.07.015_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/14737140.6.1.43","article-title":"Hormonal therapy in epithelial ovarian cancer","volume":"6","author":"Rao","year":"2006","journal-title":"Expert. Rev. Anticancer Ther."},{"key":"10.1016\/j.mce.2008.07.015_bib34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10937400701876095","article-title":"Risk factors for ovarian cancer: an overview with emphasis on hormonal factors","volume":"11","author":"Salehi","year":"2008","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"10.1016\/j.mce.2008.07.015_bib35","first-page":"386","article-title":"17\u03b2-Hydroxysteroid dehydrogenase in common epithelial ovarian tumors","volume":"9","author":"Sasano","year":"1996","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.mce.2008.07.015_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02739947","article-title":"From endocrinology to intracrinology","volume":"9","author":"Sasano","year":"1998","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.mce.2008.07.015_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2325\/jbcs.13.129","article-title":"New development in intracrinology of breast cancer","volume":"13","author":"Sasano","year":"2006","journal-title":"Breast Cancer"},{"key":"10.1016\/j.mce.2008.07.015_bib38","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1158\/1078-0432.CCR-06-2878","article-title":"Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients","volume":"13","author":"Smyth","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2008.07.015_bib39","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1158\/1078-0432.CCR-05-1996","article-title":"Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor","volume":"12","author":"Stanway","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2008.07.015_bib40","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1124\/jpet.105.091587","article-title":"Tibolone metabolism in human liver is catalyzed by 3\u03b1\/3\u03b2-hydroxysteroid dehydrogenase activities of the four isoforms of the also-keto reductase (AKR)1C subfamily","volume":"316","author":"Steckelbroeck","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.mce.2008.07.015_bib41","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol. 18"},{"key":"10.1016\/j.mce.2008.07.015_bib42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ijc.2910320404","article-title":"Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in non-diseased tissue and in benign and malignant tumors of the human ovary","volume":"32","author":"Vierikko","year":"1983","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mce.2008.07.015_bib43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ygyno.2007.05.009","article-title":"Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer","volume":"106","author":"Walker","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mce.2008.07.015_bib44","first-page":"491","article-title":"Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies","volume":"146","author":"Watanabe","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2008.07.015_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-4731(85)90142-6","article-title":"Aromatization of androstenedione by normal and neoplastic endometrium in the uterus","volume":"22","author":"Yamki","year":"1985","journal-title":"J. Steroid Biochem."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720708003298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720708003298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T19:25:15Z","timestamp":1545852315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720708003298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0303720708003298"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2008.07.015","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}